CV autonomic neuropathy risk for CVD despite albumin status

CV autonomic neuropathy risk for CVD despite albumin status
Cardiovascular autonomic neuropathy appears to affect the risk of cardiovascular disease even in type 1 diabetes patients with normal albumin excretion rates, according to a study published online April 12 in Diabetes.

(HealthDay) -- Cardiovascular autonomic neuropathy (CAN) appears to affect the risk of cardiovascular disease even in type 1 diabetes patients with normal albumin excretion rates, according to a study published online April 12 in Diabetes.

Noting that CAN is present in about a quarter of patients with type 1 diabetes, Ulrik Madvig Mogensen, M.D., from the University Hospital of Copenhagen in Denmark, and colleagues measured coronary artery plaque burden, coronary artery calcium, left ventricular function, and blood pressure and pulse pressure over a 24-hour period in 56 normoalbuminuric type 1 , 26 of whom had CAN.

The researchers found that, compared with patients without CAN, patients with CAN had higher coronary artery calcium scores. For patients with CAN, a nonsignificant trend was noted toward higher prevalence of coronary plaques and flow-limiting stenosis. After controlling for various factors, there was an independent association between CAN and higher scores, subtle impairment of left ventricular systolic and , and higher pulse pressure.

"In conclusion, CAN in normoalbuminuric type 1 diabetic patients is associated with distinct signs of subclinical cardiovascular disease," Mogensen and colleagues conclude.

One author was supported by a scholarship from .

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

High blood sugar lowers chances of surviving a heart attack

Mar 26, 2012

Patients with high blood sugar run an increased risk of dying if they have a heart attack, and diabetics are less likely to survive in-hospital cardiac arrest than non-diabetics, reveals research at the Sahlgrenska Academy, ...

Recommended for you

Appropriate use criteria established for pediatric ECHO

10 hours ago

(HealthDay)—Appropriate use criteria have been developed for the initial use of transthoracic echocardiography in outpatient pediatric cardiology. The guidelines were published online Sept. 29 in the Journal of ...

Fish oil supplements don't prevent recurrence of A-fib

Sep 30, 2014

(HealthDay)—High doses of fish oil supplements won't prevent recurrence of atrial fibrillation (AF), Canadian researchers report. The study, funded by the Canadian Institutes for Health Research and the ...

User comments